Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Scientist describes her pioneering work to make medical cannabis effective, safe and standardized

Cannabis compounds are widely recognized as effective treatments for a surprising number of conditions and illnesses from anxiety to asthma to autism – and that’s just the A’s on a very long list.

Yet it wasn’t long ago that cannabis was best known as marijuana, the “devil weed” with psychoactive effects that caused most countries to ban even growing the plant whose dried flowers people smoked to get high.

Well, now that medical cannabis is emerging as a legitimate wonder drug, there is an urgent need for guidelines on how to grow different strains to maximize their therapeutic potential, and to determine which strains best treat different conditions. No less urgent is the need for standardizing cannabis-based pharmaceuticals.

There’s one Israeli scientist taking on these major challenges.

Read the full article at Israel21c (Abigail Klein Leichman)

Publication date: